These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20088742)

  • 41. Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis.
    Yue X; Lin X; Yang T; Yang X; Yi X; Jiang X; Li X; Li T; Guo J; Dai Y; Shi J; Wei L; Youker KA; Torre-Amione G; Yu Y; Andrade KC; Chang J
    Hypertension; 2016 Mar; 67(3):597-605. PubMed ID: 26781283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors.
    Vuorio T; Jauhiainen S; Ylä-Herttuala S
    Expert Opin Biol Ther; 2012 Jan; 12(1):79-92. PubMed ID: 22115316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary angiogenic effect of long-term administration of Nigella sativa.
    Al Asoom LI
    BMC Complement Altern Med; 2017 Jun; 17(1):308. PubMed ID: 28610577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review.
    Kusumanto YH; Hospers GA; Mulder NH; Tio RA
    Int J Cardiovasc Intervent; 2003; 5(1):27-34. PubMed ID: 12623562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.
    Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN
    Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Role of CC-Chemokines in the Regulation of Angiogenesis.
    Ridiandries A; Tan JT; Bursill CA
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic angiogenesis for revascularization in peripheral artery disease.
    Grochot-Przeczek A; Dulak J; Jozkowicz A
    Gene; 2013 Aug; 525(2):220-8. PubMed ID: 23566831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiogenic and Antiangiogenic mechanisms of high density lipoprotein from healthy subjects and coronary artery diseases patients.
    Li HM; Mo ZW; Peng YM; Li Y; Dai WP; Yuan HY; Chang FJ; Wang TT; Wang M; Hu KH; Li XD; Ning DS; Chen YT; Song YK; Lu XL; Pei Z; Dong YG; Wang ZP; Zhang X; Xu YQ; Wang SM; Ou ZJ; Ou JS
    Redox Biol; 2020 Sep; 36():101642. PubMed ID: 32863238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sequential Bone-Marrow Cell Delivery of VEGFA/S1P Improves Vascularization and Limits Adverse Cardiac Remodeling After Myocardial Infarction in Mice.
    Żak MM; Gkontra P; Clemente C; Squadrito ML; Ferrarini A; Mota RA; Oliver E; Rocha S; Agüero J; Vázquez J; De Palma M; Ibáñez B; Arroyo AG
    Hum Gene Ther; 2019 Jul; 30(7):893-905. PubMed ID: 30786776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospects for therapeutic inhibition of neuroblastoma angiogenesis.
    Shusterman S; Maris JM
    Cancer Lett; 2005 Oct; 228(1-2):171-9. PubMed ID: 15927358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical use of intracoronary gene transfer of fibroblast growth factor for coronary artery disease.
    Penny WF; Hammond HK
    Curr Gene Ther; 2004 Jun; 4(2):225-30. PubMed ID: 15180588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiogenic protein therapy.
    Ruel M; Sellke FW
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):222-35. PubMed ID: 12973700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VEGF gene therapy for coronary artery disease and peripheral vascular disease.
    Rasmussen HS; Rasmussen CS; Macko J
    Cardiovasc Radiat Med; 2002; 3(2):114-7. PubMed ID: 12699842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiogenic therapy for coronary artery and peripheral arterial disease.
    Hughes GC; Annex BH
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):521-35. PubMed ID: 15889979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene therapy to stimulate angiogenesis to treat diffuse coronary artery disease.
    Kaminsky SM; Rosengart TK; Rosenberg J; Chiuchiolo MJ; Van de Graaf B; Sondhi D; Crystal RG
    Hum Gene Ther; 2013 Nov; 24(11):948-63. PubMed ID: 24164242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene therapy for myocardial angiogenesis: has it come of age?
    Kantor B; Altman J; Simari RS; Bayes-Genis A; Keelan PJ; Holmes DR; Schwartz RS
    Curr Atheroscler Rep; 2000 Sep; 2(5):373-9. PubMed ID: 11122768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy.
    Pasqualetti G; Danesi R; Del Tacca M; Bocci G
    Pharmacogenomics; 2007 Jan; 8(1):49-66. PubMed ID: 17187509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease.
    Isner JM; Walsh K; Symes J; Pieczek A; Takeshita S; Lowry J; Rossow S; Rosenfield K; Weir L; Brogi E
    Circulation; 1995 Jun; 91(11):2687-92. PubMed ID: 7538919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.